Related Experiment Video
Updated: Jul 6, 2025

06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.9K
nSEA: n-Node Subnetwork Enumeration Algorithm Identifies Lower Grade Glioma Subtypes with Altered Subnetworks and
Zhihan Zhang1, Christiana Wang, Ziyin Zhao
1Systems Biology and Bioinformatics Graduate Program, Case Western Reserve University, Cleveland OH 44106, USA, zhihan.zhang@case.edu.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|December 31, 2023
Summary
Network-based Subnetwork Enumeration and Analysis (nSEA) identified five low-grade glioma (LGG) patient groups, revealing a novel subgroup with distinct clinical features and potential treatment implications.
Area of Science:
- Oncology
- Bioinformatics
- Systems Biology
Background:
- Molecular characterization advances necessitate LGG classification beyond histology.
- Existing methods lack comprehensive molecular subtyping for low-grade gliomas.
Purpose of the Study:
- To develop and apply a novel network-based approach for molecular classification of low-grade glioma (LGG).
- To identify distinct LGG patient subgroups based on dysregulated molecular pathways.
- To uncover previously unidentified patient subgroups and their clinical relevance.
Main Methods:
- Utilized gene expression profiles from 516 LGG patients and a protein-protein interaction network.
- Employed network-based Subnetwork Enumeration and Analysis (nSEA) for unsupervised patient clustering.
- Identified 92 subnetworks to categorize patients into five distinct molecular groups.
Main Results:
- nSEA successfully classified LGG patients into five molecular groups.
- A novel patient subgroup lacking EGFR, NF1, and PTEN mutations was identified with unique clinical features.
- Validation on an independent dataset confirmed the robustness and survival consistency of the identified groups.
Conclusions:
- This study provides a comprehensive molecular classification of LGG, extending beyond traditional genetic markers.
- The identified patient subgroups, including the novel one, offer insights for improved prognosis and personalized treatment strategies.
- The network-based approach highlights the synergistic interactions of driver genes and the biological relevance of molecular subnetworks in LGG.

